CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,000 | +4.2% | 63,017 | 0.0% | 0.00% | – |
| Q3 2016 | $24,000 | +9.1% | 63,017 | -0.9% | 0.00% | – |
| Q2 2016 | $22,000 | -38.9% | 63,588 | -6.7% | 0.00% | – |
| Q1 2016 | $36,000 | -39.0% | 68,146 | +42.9% | 0.00% | – |
| Q4 2015 | $59,000 | 0.0% | 47,695 | +18.2% | 0.00% | – |
| Q3 2015 | $59,000 | -28.9% | 40,362 | -4.5% | 0.00% | – |
| Q2 2015 | $83,000 | +13.7% | 42,283 | +4.4% | 0.00% | – |
| Q1 2015 | $73,000 | -3.9% | 40,504 | +26.1% | 0.00% | – |
| Q4 2014 | $76,000 | +13.4% | 32,123 | +17.3% | 0.00% | – |
| Q3 2014 | $67,000 | -65.1% | 27,378 | -59.8% | 0.00% | – |
| Q2 2014 | $192,000 | – | 68,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 191,000 | $345,710,000 | 0.34% |
| TFS CAPITAL LLC | 1,182,304 | $2,140,000 | 0.21% |
| TURNER INVESTMENTS LLC | 530,100 | $959,000 | 0.17% |
| DRW Securities, LLC | 486,953 | $881,000 | 0.14% |
| Candriam S.C.A. | 1,445,000 | $2,616,000 | 0.05% |
| First Heartland Consultants, Inc. | 74,624 | $135,000 | 0.05% |
| WASHINGTON TRUST Co | 410,616 | $743,000 | 0.05% |
| EAGLE ASSET MANAGEMENT INC | 4,332,630 | $7,842,000 | 0.04% |
| JW Asset Management, LLC | 52,271 | $95,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 702,571 | $1,272,000 | 0.03% |